Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder - Possible Role for Methoxyindole Pathway
10.1371/journal.pone.0068283
Saved in:
Main Authors: | Zhu, H., Bogdanov, M.B., Boyle, S.H., Matson, W., Sharma, S., Matson, S., Churchill, E., Fiehn, O., Rush, J.A., Krishnan, R.R., Pickering, E., Delnomdedieu, M., Kaddurah-Daouk, R. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110608 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: A proof of concept
by: Kaddurah-Daouk, R., et al.
Published: (2014) -
Progress for pharmacometabolomics and its applications
by: Huang, Y., et al.
Published: (2014) -
Opioid use affects antioxidant activity and purine metabolism: Preliminary results
by: Mannelli, P., et al.
Published: (2014) -
Alterations in tryptophan and purine metabolism in cocaine addiction: A metabolomic study
by: Patkar, A.A., et al.
Published: (2014) -
Bioequivalence study of 50 mg sertraline tablets in healthy Thai volunteers
by: Suvimol Niyomnaitham, et al.
Published: (2018)